Troponin Market Rising with Tremendous Growth of 8.7% CAGR during 2020-2024 | Abbott, Roche, Siemens Healthcare, Biomerieux, Mitsubishi, Quidel

The exclusive research report on Global Troponin market 2020 categorizes the market based on market overview, regions, analysis by types and applications, market dynamics, manufacturers profiles and forecast 2020-2024.

Global Troponin Market overview:

Troponin Market leading manufacturers in the sector are Abbott, Roche and Siemens Healthcare, with revenue ratios of 28.303%, 21.249% and 10.063% in 2019. Troponin market size maintain the average annual growth rate of 0.057944581468 from 830.0 million $ in 2014 to 1100.0 million $ in 2018. The global Troponin market is valued at US$ 1236.8 million in 2019 is expected to reach US$ 2173.2 million by the end of 2024, growing at a CAGR of 8.7% during 2020-2024.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/139658 .

Troponins are a group of proteins found in skeletal and heart (cardiac) muscle fibers that regulate muscular contraction. Troponin tests measure the level of cardiac-specific troponin in the blood to help detect heart injury. The Global Troponin Market is segmented on the basis of Product Type, Application, End Use Industry and Region.

On the Basis of Product Type segment, the Troponin Market is sub segmented into Troponin I (TnI) and Troponin T (TnT). Based on End Use Industry segment, the Troponin Market is sub segmented into Myocardial Infarction and Acute Coronary Syndrome.

Some of the Troponin Market manufacturers involved in the market are Abbott, Roche, Siemens Healthcare, Beckman Coulter, Biomerieux, Mitsubishi, Quidel, Getein Biotech, Improve Medical, Response Biomedical in World, effective mergers are some of the strategies adopted by the Troponin Market manufacturers. New product launches and continuous technological innovations are the Troponin Market strategies adopted by the major players.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Troponin Market Report 2020" @ https://www.businessindustryreports.com/buy-now/139658/single .

Through the statistical analysis, the report depicts the international Troponin Market including capacity, production, production value, cost/profit, supply/demand and global import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.

There are several manufacturers of Troponin in Europe and North America. In North America, the demand for Troponin is primarily driven by the healthcare sector. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India. These countries have been witnessing rapid increase in its population along with expansion of their overall economies, which has led to increase in disposable income.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/139658 .

Top Industry News:

ABBOTT'S FREESTYLE LIBRE 14 DAY SYSTEM NOW AVAILABLE IN U.S. FOR HOSPITALIZED PATIENTS WITH DIABETES DURING COVID-19 PANDEMIC ON 08 APRIL, 2020 -- Abbott announced today that the FreeStyle Libre 14 day system, the world's leading continuous glucose monitoring (CGM) technology, can now be used in the hospital setting during the COVID-19 pandemic, according to the U.S. Food and Drug Administration (FDA). This will permit frontline healthcare workers to remotely monitor patients with diabetes receiving inpatient care by assessing real-time glucose levels and glucose history. To help hospitals and medical centers in COVID-19 outbreak hotspots ramp up access to the technology, Abbott will donate 25,000 FreeStyle Libre 14 day sensors in partnership with the American Diabetes Association (ADA), Insulin for Life USA and Diabetes Disaster Response Coalition.

According to a recent report by the Centers for Disease Control and Prevention (CDC), more than 50% of people with diabetes who have been diagnosed with COVID-19 are hospitalized.

"There's been a spike in demand for health technology as hospitals are looking for ways to minimize COVID-19 exposure, especially to high-risk patients such as people with chronic conditions like diabetes," said Eugene E. Wright, Jr., M.D., medical director for performance improvement, Charlotte Area Health Education Center in North Carolina. "Having access to technology like FreeStyle Libre 14 day system allows physicians to keep a close eye on hospitalized patients while minimizing transmission risks, PPE use and contact with hospital staff."

With a one-second scan using a reader or smartphone over the FreeStyle Libre 14 day sensor worn on the back of the upper arm, users get real-time glucose readings every minute, historical trends and patterns, and arrows showing where glucose levels are going without having to fingerstick. At the same time, physicians will receive real-time glucose data and actionable information to help make important treatment decisions through LibreView, a secure, cloud-based diabetes management system. Recent studies showed that users of the FreeStyle Libre 14 day system have improved glucose control, decreased time in hyperglycemia and hypoglycemia as well as reduced hospitalizations, and HbA1C levels.

"We appreciate the FDA's quick action to make medical products available during this public health crisis," said Jared Watkin, senior vice president, Diabetes Care, Abbott. "By working with our partners at the American Diabetes Association to arm frontline healthcare workers with FreeStyle Libre technology, Abbott will enable them to protect and monitor their patients with diabetes, limit COVID-19 exposure and also manage the influx of critical care needs."

Table of Contents:

1 Troponin Product Definition
2 Global Troponin Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Troponin Shipments
2.2 Global Manufacturer Troponin Business Revenue
2.3 Global Troponin Market Overview
3 Manufacturer Troponin Business Introduction
3.1 Abbott Troponin Business Introduction
3.1.1 Abbott Troponin Shipments, Price, Revenue and Gross profit 2020-2024
3.1.2 Abbott Troponin Business Distribution by Region
3.1.3 Abbott Interview Record
3.1.4 Abbott Troponin Business Profile
3.1.5 Abbott Troponin Product Specification
3.2 Roche Troponin Business Introduction
3.2.1 Roche Troponin Shipments, Price, Revenue and Gross profit 2020-2024
3.2.2 Roche Troponin Business Distribution by Region
3.2.3 Interview Record
3.2.4 Roche Troponin Business Overview
3.2.5 Roche Troponin Product Specification
3.3 Siemens Healthcare Troponin Business Introduction
3.3.1 Siemens Healthcare Troponin Shipments, Price, Revenue and Gross profit 2020-2024
3.3.2 Siemens Healthcare Troponin Business Distribution by Region
3.3.3 Interview Record
3.3.4 Siemens Healthcare Troponin Business Overview
3.3.5 Siemens Healthcare Troponin Product Specification
3.4 Beckman Coulter Troponin Business Introduction
3.5 Biomerieux Troponin Business Introduction
3.6 Mitsubishi Troponin Business Introduction
................... Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.